Application of Bioinformatics Tools for the Prediction of Helper MicroRNAs for Improvement of Oncolytic Virus Efficacy

Purpose. Oncolytic Reoviruses, as a self-limiting virus, can be used in cancer treatment, because they have the ability to replicate in tumor cells selectively and destroy them. Studies show that some immune response proteins may interfere with the virus life cycle. So, the main aim of this bioinfor...

Full description

Bibliographic Details
Main Authors: Nasrin Rastegarvand, Hoorieh Soleimanjahi, Ehsan Arefian, Mahmoud Reza Pourkarim
Format: Article
Language:English
Published: Hindawi-Wiley 2022-01-01
Series:Cellular Microbiology
Online Access:http://dx.doi.org/10.1155/2022/5756131
_version_ 1797958212389961728
author Nasrin Rastegarvand
Hoorieh Soleimanjahi
Ehsan Arefian
Mahmoud Reza Pourkarim
author_facet Nasrin Rastegarvand
Hoorieh Soleimanjahi
Ehsan Arefian
Mahmoud Reza Pourkarim
author_sort Nasrin Rastegarvand
collection DOAJ
description Purpose. Oncolytic Reoviruses, as a self-limiting virus, can be used in cancer treatment, because they have the ability to replicate in tumor cells selectively and destroy them. Studies show that some immune response proteins may interfere with the virus life cycle. So, the main aim of this bioinformatic study is to check which microRNA is able to target some reovirus inhibitory proteins. Experimental Design. By use of online bioinformatics software, the microRNAs that could target inhibitory genes were selected. Then, other features like content ++ score and cell type were checked and finally the eligible microRNAs were determined. Results. After choosing 15 inhibitory proteins, analysis was performed and finally 37 microRNAs which could target inhibitory proteins in colorectal cell lines were selected. In the end, by investigation of web-based tools, just two microRNAs were finalized. Conclusions and Clinical Relevance. This bioinformatic study shows that microRNA-140 and microRNA-92a have the potential to target some inhibitory proteins which interfere with oncolytic Reovirus replication and it may help in the optimal use of this virus as a cancer treatment. Because selective reproduction of Reovirus in tumor cells, as a nonchemical therapy, can be a good way to overcome this disease with broad advantages.
first_indexed 2024-04-11T00:16:51Z
format Article
id doaj.art-c68e670855b649d6888db794485f30ed
institution Directory Open Access Journal
issn 1462-5822
language English
last_indexed 2024-04-11T00:16:51Z
publishDate 2022-01-01
publisher Hindawi-Wiley
record_format Article
series Cellular Microbiology
spelling doaj.art-c68e670855b649d6888db794485f30ed2023-01-09T01:30:23ZengHindawi-WileyCellular Microbiology1462-58222022-01-01202210.1155/2022/5756131Application of Bioinformatics Tools for the Prediction of Helper MicroRNAs for Improvement of Oncolytic Virus EfficacyNasrin Rastegarvand0Hoorieh Soleimanjahi1Ehsan Arefian2Mahmoud Reza Pourkarim3Department of VirologyDepartment of VirologyDepartment of MicrobiologyLaboratory for Clinical and Epidemiological VirologyPurpose. Oncolytic Reoviruses, as a self-limiting virus, can be used in cancer treatment, because they have the ability to replicate in tumor cells selectively and destroy them. Studies show that some immune response proteins may interfere with the virus life cycle. So, the main aim of this bioinformatic study is to check which microRNA is able to target some reovirus inhibitory proteins. Experimental Design. By use of online bioinformatics software, the microRNAs that could target inhibitory genes were selected. Then, other features like content ++ score and cell type were checked and finally the eligible microRNAs were determined. Results. After choosing 15 inhibitory proteins, analysis was performed and finally 37 microRNAs which could target inhibitory proteins in colorectal cell lines were selected. In the end, by investigation of web-based tools, just two microRNAs were finalized. Conclusions and Clinical Relevance. This bioinformatic study shows that microRNA-140 and microRNA-92a have the potential to target some inhibitory proteins which interfere with oncolytic Reovirus replication and it may help in the optimal use of this virus as a cancer treatment. Because selective reproduction of Reovirus in tumor cells, as a nonchemical therapy, can be a good way to overcome this disease with broad advantages.http://dx.doi.org/10.1155/2022/5756131
spellingShingle Nasrin Rastegarvand
Hoorieh Soleimanjahi
Ehsan Arefian
Mahmoud Reza Pourkarim
Application of Bioinformatics Tools for the Prediction of Helper MicroRNAs for Improvement of Oncolytic Virus Efficacy
Cellular Microbiology
title Application of Bioinformatics Tools for the Prediction of Helper MicroRNAs for Improvement of Oncolytic Virus Efficacy
title_full Application of Bioinformatics Tools for the Prediction of Helper MicroRNAs for Improvement of Oncolytic Virus Efficacy
title_fullStr Application of Bioinformatics Tools for the Prediction of Helper MicroRNAs for Improvement of Oncolytic Virus Efficacy
title_full_unstemmed Application of Bioinformatics Tools for the Prediction of Helper MicroRNAs for Improvement of Oncolytic Virus Efficacy
title_short Application of Bioinformatics Tools for the Prediction of Helper MicroRNAs for Improvement of Oncolytic Virus Efficacy
title_sort application of bioinformatics tools for the prediction of helper micrornas for improvement of oncolytic virus efficacy
url http://dx.doi.org/10.1155/2022/5756131
work_keys_str_mv AT nasrinrastegarvand applicationofbioinformaticstoolsforthepredictionofhelpermicrornasforimprovementofoncolyticvirusefficacy
AT hooriehsoleimanjahi applicationofbioinformaticstoolsforthepredictionofhelpermicrornasforimprovementofoncolyticvirusefficacy
AT ehsanarefian applicationofbioinformaticstoolsforthepredictionofhelpermicrornasforimprovementofoncolyticvirusefficacy
AT mahmoudrezapourkarim applicationofbioinformaticstoolsforthepredictionofhelpermicrornasforimprovementofoncolyticvirusefficacy